Home/Filings/3/0001104659-18-019897
3//SEC Filing

Novartis Institutes for BioMedical Research, Inc. 3

Accession 0001104659-18-019897

CIK 0001652130other

Filed

Mar 22, 8:00 PM ET

Accepted

Mar 23, 5:29 PM ET

Size

5.7 KB

Accession

0001104659-18-019897

Insider Transaction Report

Form 3
Period: 2018-03-16
Holdings
  • Common Stock

    4,277,073
Footnotes (1)
  • [F1]The shares are held directly by Novartis Institutes for BioMedical Research, Inc. ("NIBRI"). NIBRI is an indirect wholly-owned subsidiary of Novartis AG.

Documents

1 file

Issuer

Intellia Therapeutics, Inc.

CIK 0001652130

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001673852

Filing Metadata

Form type
3
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 5:29 PM ET
Size
5.7 KB